civil-litigation intellectual-property patent-litigation federal-courts court-watch trial

Astellas Pharma v. Lupin Ltd.: Jury Trial Concludes

23-cv-00819
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

A jury trial concluded in Astellas Pharma Inc. and others v. Lupin Ltd. and others, docket 23-cv-00819. The court is unspecified, and the trial outcome has not been publicly disclosed.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

  • jury trial concluded
  • pharmaceutical patent or infringement
  • undisclosed verdict
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
fact_check

Docket Snapshot

account_balance

Court

Court not identified

Awaiting court metadata

tag

Docket

Not captured

Civil

timeline

Stage

Active litigation

Active

event

Filed

Date unavailable

Not in the available feed

new_releases

Latest Filing

1:23-cv-00819 Astellas Pharma Inc. et al v. Lupin Ltd. et al

Other · May 04, 2026

newspaper

Coverage

1 article

1 source tracked

groups

Participants

1 Defendant, 1 Plaintiff, 1 Related Organization

3 linked entities

gavel

Judge

Not assigned in feed

What the record shows

The court metadata has not been resolved yet, so Juryvine is keeping the page conservative until a reliable court match lands.

The newest docket activity we have is a other dated May 04, 2026.

The visible party/entity graph currently includes Lupin Limited, Astellas Pharma Inc and others.

Press monitoring has found 1 related article from 1 distinct source.

chronic

The Story So Far

Updated 4 days, 16 hours ago

Astellas Pharma Inc. et al v. Lupin Ltd. et al is an active civil matter under docket 23-cv-00819.

The main identified plaintiff or petitioner is 1:23-cv-00819 Astellas Pharma Inc. The case is currently organized around completed trial, docket number.

The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.

On May 4, 2026, the docket recorded a other: A jury trial in the case of Astellas Pharma Inc. et al has concluded. This trial was part of a larger patent dispute between the two pharmaceutical companies.

The outcome of the trial will determine the validity of certain patents related.

The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.

smart_toy Juryvine case narrative generated from the full docket timeline. How we verify our work.
Advertisement

Case Timeline

1 event
info
Other May 4, 2026

1:23-cv-00819 Astellas Pharma Inc. et al v. Lupin Ltd. et al

A jury trial in the case of Astellas Pharma Inc. et al v. Lupin Ltd. et al has concluded. This trial was part of a larger patent dispute between the two pharmaceutical companies. The outcome of the trial will determine the validity of certain patents related to the companies' products.

Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

2 days, 22 hours ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.